MWR
ABBV icon

McAdams Wright Ragen’s AbbVie ABBV Stock Holding History

McAdams Wright Ragen’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$35.8M Buy
+620,414
New +$34.4M 2% 6
2014
Q2 		– Sell
-507,091
Closed -$26.1M – 397
2014
Q1 		$26.1M Buy
507,091
+196,793
+63% +$9.95M 1.62% 13
2013
Q4 		$16.4M Buy
310,298
+63,176
+26% +$3.1M 1.08% 24
2013
Q3 		$11.1M Buy
247,122
+208,989
+548% +$9.26M 0.87% 29
2013
Q2 		$1.58M Buy
+38,133
New +$1.67M 0.13% 132

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

McAdams Wright Ragen's ABBV Position: Q3 2014 in Review

McAdams Wright Ragen opened a new position in AbbVie (ABBV) in Q3 2014: 620,414 shares worth $35.8M. The stake represents 2% of the portfolio and ranks #6 among its holdings. This is a return to the name: McAdams Wright Ragen previously reported a position in ABBV as recently as Q1 2014.

McAdams Wright Ragen first reported a position in ABBV in Q2 2013 and has held it in 5 quarters since. 1,501 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

  • McAdams Wright Ragen held 620,414 shares of AbbVie worth $35.8M as of Q3 2014.
  • AbbVie was a new McAdams Wright Ragen position in Q3 2014.
  • AbbVie made up 2% of McAdams Wright Ragen's portfolio in Q3 2014, its #6 holding.
  • McAdams Wright Ragen first reported a position in AbbVie in Q2 2013 and has held it in 5 quarters since.
  • 1,501 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.